Welcome Josh Andersen!
Josh Andersen, PhD, is an associate professor in the Department of Oncological Sciences and started on September 1, 2023.
"All projects in our lab are tied together by a common interest in cancer cell signaling—specifically, how post-translational mechanisms control key aspects of tumor cell biology, including innate immune signaling, autophagy, cell survival, and growth. Our research is mechanism-focused, but also angled toward translational endpoints, including drug development. Because our research is question-driven, it relies on a variety of approaches from cell biology, biochemistry, computer coding/modeling, and mass spectrometry to uncover targetable mechanisms of tumor cell biology."
